ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Eyetech Pharmaceuticals (MM)

Eyetech Pharmaceuticals (MM) (EYET)

0.00
0.00
(0.00%)
Closed February 04 4:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

EYET Latest News

OSI Pharmaceuticals and Eyetech Pharmaceuticals Confirm November 14th Closing

OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) and Eyetech Pharmaceuticals, Inc. (NASDAQ: EYET) today announced that the closing of the OSI acquisition of Eyetech will occur on Monday, November...

Eyetech Provides Update on Status of Pending Acquisition by OSI Pharmaceuticals

Stockholders Overwhelmingly Approve Merger NEW YORK, Nov. 10 /PRNewswire-FirstCall/ -- Eyetech Pharmaceuticals, Inc. (NASDAQ:EYET) provided an update today on the status of its pending...

Eyetech Reports Third Quarter 2005 Financial Results

Company achieves operating profitability, excluding certain charges, based on total revenue of $67.4 million and net product revenue of $55.5 million NEW YORK, Oct. 31 /PRNewswire-FirstCall/...

Eyetech Announces Enrollment of the First Patient in a Phase 3 Clinical Trial of Macugen(R) (pegaptanib sodium injection) in Dia

Phase 2 study of Macugen in diabetic macular edema (DME) published in the October issue of Ophthalmology NEW YORK, Oct. 17 /PRNewswire-FirstCall/ .- Eyetech Pharmaceuticals, Inc. (NASDAQ:EYET...

Recent Analyses Suggest That Treatment With Macugen(R) (pegaptanib sodium injection) May Provide Better Results for Patients Wit

Retrospective, subgroup analyses of the VISION study suggest that treatment of early disease with Macugen may further reduce the risk of vision loss associated with neovascular AMD compared to the...

Macugen(R) (pegaptanib sodium injection) Receives Positive Opinion for Treatment of Neovascular Age-Related Macular Degeneration

NEW YORK, Sept. 16 /PRNewswire-FirstCall/ -- Eyetech Pharmaceuticals, Inc. (NASDAQ:EYET) announced today that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee...

OSI Pharmaceuticals and Eyetech Pharmaceuticals Announce Signing of Definitive Merger Agreement

Acquisition Projected to be Accretive and Generate Combined 2006 Revenues of Over $600 Million MELVILLE, N.Y. and NEW YORK, Aug. 21 /PRNewswire-FirstCall/ -- OSI Pharmaceuticals, Inc...

OSI Pharmaceuticals and Eyetech Pharmaceuticals Announce Signing of Definitive Merger Agreement; Acquisition Projected to be Acc

OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) and Eyetech Pharmaceuticals, Inc. (NASDAQ: EYET) today announced that they have entered into a definitive merger agreement whereby OSI has agreed...

Macugen(R) (pegaptanib sodium injection) Named Innovative Pharmaceutical Product Of The Year At The 2005 Pharmaceutical Achievem

Award recognizes Macugen's breakthrough technology as the first anti- angiogenic treatment approved in ophthalmology and the first aptamer therapy approved by the FDA NEW YORK, Aug. 9...

Eyetech Reports Second Quarter 2005 Financial Results

Eyetech Reports Second Quarter 2005 Financial Results - Gross Product Revenue for Macugen(R) (pegaptanib sodium injection) increased to $50 million in the second quarter from $25 million in the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

EYET - Frequently Asked Questions (FAQ)

What is the current Eyetech share price?
The current share price of Eyetech is $ 0.00
What is the 1 year trading range for Eyetech share price?
Eyetech has traded in the range of $ 0.00 to $ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
IVVDInvivyd Inc
$ 1.055
(194.94%)
448.53M
HCWBHCW Biologics Inc
$ 0.6265
(125.20%)
344.42M
UOKAMDJM Ltd
$ 0.2293
(76.38%)
354.09M
GHRSGH Research PLC
$ 17.9991
(69.80%)
10.31M
WHLRLWheeler Real Estate Investment Trust Inc
$ 234.64
(61.82%)
392
CYNCYNGN Inc
$ 0.1169
(-56.70%)
75.52M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.1943
(-54.61%)
327.95M
VIRXViracta Therapeutics Inc
$ 0.0741
(-51.09%)
9.37M
BOWNUBowen Acquisition Corporation
$ 3.39
(-49.55%)
17.28k
PITAHeramba Electric PLC
$ 0.503
(-44.11%)
1.37M
IVVDInvivyd Inc
$ 1.055
(194.94%)
431.26M
BHATBlue Hat Interactive Entertainment Technology
$ 0.0462
(27.98%)
400.25M
NVDANVIDIA Corporation
$ 116.66
(-2.84%)
333.74M
UOKAMDJM Ltd
$ 0.2293
(76.38%)
326.81M
HCWBHCW Biologics Inc
$ 0.6265
(125.20%)
320.82M

Discussion

View Full Feed
janice shell janice shell 4 minutes ago
I think this was my second of the year, too.
PLUS1USD
JustGoDeep JustGoDeep 5 minutes ago
I do. Last year I got a LOT of tens, this year only 3.

Actually only 2. I just got my first one this year.
PLUS1USD
trunkmonk trunkmonk 6 minutes ago
huh, Im not sure your looking at it properly. The government is going to own funds, just like me and you do, stocks, bonds, gold, silver, crypto(XRP). Treasury will own it, and the products they pick will be managed by fund managers. 47 had a meeting with Brad, and im sure he is gonna have one with
FNMA
CrimsonNightRider CrimsonNightRider 7 minutes ago
Yeah - 👍🏼 what happened to that large due diligence package?

https://investorshub.advfn.com/uimage/uploads/2024/6/27/yeyue08586095-F2C8-4F91-B2F0-EB62D892498B.jpeg
ASTA
janice shell janice shell 7 minutes ago
I don't remember to claim mine very often. Once upon a time, I never missed a day.
PLUS1USD
Biotechotcguy Biotechotcguy 7 minutes ago
Nothing yet huh.  This is boring lol 
DROR
JustGoDeep JustGoDeep 8 minutes ago
Nah, 1 of every 100 wins. I think many of us still take the coins.

Obviously at least 200+
PLUS1USD
zerosnoop zerosnoop 8 minutes ago
So a U.S. government-supported financial institution specializing in global trade financing is backing the PROVEN AOT as per the FACTS in the RECENT PR below.


https://www.accesswire.com/959008/qs-energy-announces-milestones-in-global-sales-activity-and-strategic-partnerships-a
QSEP
pegs1 pegs1 8 minutes ago
Gunny
I pray that you are right for all investors!
CRTG
zerosnoop zerosnoop 9 minutes ago
I notice the paid bashers, tax cheats, fraudsters, grubs, uneducated fools with a low IQ & compulsive liars are getting more desperate with their nonsense. The short squeeze is fast approaching. The PROVEN AOT is going GLOBAL.

NAKED SHORT SELLING gets reported differently & isn't part
QSEP
jimr1717 jimr1717 9 minutes ago
A bag holder is an informal term used to describe an investor who holds a position in a security that decreases in value until it descends into worthlessness. In most cases, the bag holder stubbornly retains their holding for an extended period, during which time the value of the investment goes to
HMBL
zerosnoop zerosnoop 10 minutes ago
The below is so TRUE in regards to QSEP

A stock basher is someone who manipulates the market to cause a drop in asset prices.

Stock bashers disseminate misinformation in the hopes that investors will believe the false claims and sell their stock before the price drops.
QSEP
nowwhat2 nowwhat2 10 minutes ago
BTC, 100k, Yada, Yada, Yada


https://investorshub.advfn.com/uimage/uploads/2025/2/3/ombvcBTC_@_3_30d_8pm_ADMIN_FUN_INAUG_TARIFF_DEEP.jpg



https://investorshub.advfn.com/uimage/uploads/2025/2/3/gfanwXRP_@_3_45d_8pm_w_btc_INAUG_DEEP_250_2018.jpg
BTCUSD
zerosnoop zerosnoop 11 minutes ago
As per Sano's other post below, he is coming to the QS shareholders meeting in February 2025. I can't wait to see Sano take on ceo & cfo Kyte, IF Sano actually shows up.

When QS held past shareholders meetings in Santa Barbara, in one's very own backyard, I know who went missing in ac
QSEP
Nukemtiltheyglow Nukemtiltheyglow 12 minutes ago
I'm truly surprised an imbecile like you would say something so stupid. Geez Louise. 
AMRN
zerosnoop zerosnoop 14 minutes ago
As per Sano's post below, he is coming to the QS shareholders meeting. I can't wait to see Sano take on engineer Gallagher, IF Sano shows up.

When QS held past shareholders meetings in Santa Barbara, in one's own backyard, I know who went missing in action time & time again. I wouldn'
QSEP
AstroGuru64 AstroGuru64 16 minutes ago
Advocacy Group, Unions Sue Treasury Department Over Illegal DOGE Data Access
FNMA
Steady_T Steady_T 17 minutes ago
Borrowing shares comes with paying a fee. Depending on the scarcity, the monthly borrow rate can be high.
NWBO
madcasper madcasper 18 minutes ago
it excites me the company is working at mining coins needing less power and increasing in value.
this one runs!

CCTL!!
CCTL

Your Recent History

Delayed Upgrade Clock